Treatment of Relapsing Mild-to-Moderate Ulcerative Colitis With the Probiotic VSL#3 as Adjunctive to a Standard Pharmaceutical Treatment: A Double-Blind, Randomized, Placebo-Controlled Study

Probiotic lactobacilli and VSL#3 induce enterocyte β-defensin 2

(2010) M. Schlee et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Probiotics in Critically Ill Patients

(2010) Karen Madsen   JOURNAL OF CLINICAL GASTROENTEROLOGY

Effect of a Probiotic Preparation (VSL#3) on Induction and Maintenance of Remission in Children With Ulcerative Colitis

(2009) Erasmo Miele et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Probiotic mixture VSL#3 protects the epithelial barrier by maintaining tight junction protein expression and preventing apoptosis in a murine model of colitis

(2009) Rudolf Mennigen et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

The Probiotic Preparation, VSL#3 Induces Remission in Patients With Mild-to-Moderately Active Ulcerative Colitis

(2009) Ajit Sood et al.   Clinical Gastroenterology and Hepatology

Ulcerative colitis and irritable bowel syndrome: relationships with quality of life

(2009) Reza Ansari et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Balancing inflammatory, lipid, and xenobiotic signaling pathways by VSL#3, a biotherapeutic agent, in the treatment of inflammatory bowel disease

(2009) C. Reiff et al.   INFLAMMATORY BOWEL DISEASES

Clinical guidelines for the management of pouchitis

(2009) Darrell S. Pardi et al.   INFLAMMATORY BOWEL DISEASES

Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism

(2009) T. A. Clayton et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

How often do patients with IBD have symptom recurrence?

(2008) Gabriele Moser   INFLAMMATORY BOWEL DISEASES

Probiotic preparation VSL#3 induces remission in children with mild to moderate acute ulcerative colitis: A pilot study

(2008) Hien Q. Huynh et al.   INFLAMMATORY BOWEL DISEASES

European evidence-based Consensus on the management of ulcerative colitis: Current management

(2008) S.P.L. Travis et al.   Journal of Crohns & Colitis

A microbial symbiosis factor prevents intestinal inflammatory disease

(2008) Sarkis K. Mazmanian et al.   NATURE